Trials / Unknown
UnknownNCT04260828
Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation Recipients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 368 (estimated)
- Sponsor
- Henan Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The anastomotic and peripheral stenosis of the transplanted kidney artery is one of the most important causes of graft failure in renal transplantation. The injury of vascular intima and the formation of microthrombosis may play a significant role in the stenosis of transplanted renal artery of recipients. Inhibiting this process with aspirin may protects against the stenosis of transplanted renal artery. This is a prospective, randomized, controlled, clinical trial to investigate the efficacy and safety of prevention of renal artery stenosis in recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin 100mg | Daily active drug administered orally for 3 months. |
| OTHER | Placebo | Sugar pill administered orally for 3 months. |
Timeline
- Start date
- 2020-02-28
- Primary completion
- 2021-12-01
- Completion
- 2022-12-01
- First posted
- 2020-02-07
- Last updated
- 2020-07-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04260828. Inclusion in this directory is not an endorsement.